GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scholar Rock Holding Corp (STU:2QK) » Definitions » Sale Of Investment

Scholar Rock Holding (STU:2QK) Sale Of Investment : €286.84 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Scholar Rock Holding Sale Of Investment?

Scholar Rock Holding's sale of investment for the three months ended in Mar. 2024 was €62.93 Mil. It means Scholar Rock Holding gained €62.93 Mil from selling investments. Scholar Rock Holding's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €286.84 Mil.

Compared with last quarter (€72.44 Mil in Dec. 2023 ), Scholar Rock Holding gained less money from selling investments in Mar. 2024 (€62.93 Mil).


Scholar Rock Holding Sale Of Investment Historical Data

The historical data trend for Scholar Rock Holding's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scholar Rock Holding Sale Of Investment Chart

Scholar Rock Holding Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial 158.66 115.66 177.00 122.72 304.44

Scholar Rock Holding Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 84.06 83.07 68.40 72.44 62.93

Scholar Rock Holding Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €286.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Scholar Rock Holding Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Scholar Rock Holding's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Scholar Rock Holding (STU:2QK) Business Description

Traded in Other Exchanges
Address
301 Binney Street, 3rd Floor, Cambridge, MA, USA, 02142
Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States. The company's lead product candidate is Apitegroma which is a highly selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGF?1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.

Scholar Rock Holding (STU:2QK) Headlines

No Headlines